These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Genetics. Mouse with human chromosome should boost Down syndrome research. Miller G Science; 2005 Sep; 309(5743):1975. PubMed ID: 16179439 [No Abstract] [Full Text] [Related]
6. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms. Rachidi M; Lopes C Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742 [TBL] [Abstract][Full Text] [Related]
9. DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects. Ahn KJ; Jeong HK; Choi HS; Ryoo SR; Kim YJ; Goo JS; Choi SY; Han JS; Ha I; Song WJ Neurobiol Dis; 2006 Jun; 22(3):463-72. PubMed ID: 16455265 [TBL] [Abstract][Full Text] [Related]
10. Production of inbred and hybrid transgenic mice carrying large (> 200 kb) foreign DNA fragments by intracytoplasmic sperm injection. Osada T; Toyoda A; Moisyadi S; Akutsu H; Hattori M; Sakaki Y; Yanagimachi R Mol Reprod Dev; 2005 Nov; 72(3):329-35. PubMed ID: 16047391 [TBL] [Abstract][Full Text] [Related]
11. Mice transgenic for reduced folate carrier: an animal model of Down syndrome? Höger J; Patterson D; Höger H; Shim KS; Bubna-Littitz H; Lubec G Amino Acids; 2009 Feb; 36(2):349-57. PubMed ID: 18414976 [TBL] [Abstract][Full Text] [Related]
12. Genetics. The critical region in trisomy 21. Nelson DL; Gibbs RA Science; 2004 Oct; 306(5696):619-21. PubMed ID: 15499000 [No Abstract] [Full Text] [Related]
13. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways. Rachidi M; Lopes C Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568 [TBL] [Abstract][Full Text] [Related]
14. Transcriptional map of the 2.5-Mb CBR-ERG region of chromosome 21 involved in Down syndrome. Dahmane N; Ghezala GA; Gosset P; Chamoun Z; Dufresne-Zacharia MC; Lopes C; Rabatel N; Gassanova-Maugenre S; Chettouh Z; Abramowski V; Fayet E; Yaspo ML; Korn B; Blouin JL; Lehrach H; Poutska A; Antonarakis SE; Sinet PM; Créau N; Delabar JM Genomics; 1998 Feb; 48(1):12-23. PubMed ID: 9503011 [TBL] [Abstract][Full Text] [Related]
15. Chromosome 21 and down syndrome: from genomics to pathophysiology. Antonarakis SE; Lyle R; Dermitzakis ET; Reymond A; Deutsch S Nat Rev Genet; 2004 Oct; 5(10):725-38. PubMed ID: 15510164 [TBL] [Abstract][Full Text] [Related]
16. Down's syndrome: critical genes in a critical region. Epstein CJ Nature; 2006 Jun; 441(7093):582-3. PubMed ID: 16738647 [No Abstract] [Full Text] [Related]
17. DSCR1 (ADAPT78) lethality: evidence for a protective effect of trisomy 21 genes? Kluetzman KS; Perez AV; Crawford DR Biochem Biophys Res Commun; 2005 Nov; 337(2):595-601. PubMed ID: 16198305 [TBL] [Abstract][Full Text] [Related]
18. Protein dysregulation in mouse hippocampus polytransgenic for chromosome 21 structures in the Down Syndrome Critical Region. Shin JH; Gulesserian T; Verger E; Delabar JM; Lubec G J Proteome Res; 2006 Jan; 5(1):44-53. PubMed ID: 16396494 [TBL] [Abstract][Full Text] [Related]
19. Molecular aspects of Down syndrome. Dutta S; Nandagopal K; Gangopadhyay PK; Mukhopadhyay K Indian Pediatr; 2005 Apr; 42(4):339-44. PubMed ID: 15876595 [TBL] [Abstract][Full Text] [Related]
20. A year of unprecedented progress in Down syndrome basic research. Reeves RH; Garner CC Ment Retard Dev Disabil Res Rev; 2007; 13(3):215-20. PubMed ID: 17910083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]